To comparative the effect of aciclovir and valaciclovir on preventing the recurrence of recurrent genital herpes

Journal of Clinical Dermatology

Volumn 40, Issue 4, 2011, Pages 213-215

  Zhang, Ling ^a   Yang, Hui Lan ^a   Liu, Zhong Rong ^a   Fan, Jian Yong ^a   Xuan, Min ^a   Long, Chao Qin ^a   Bi, Jian Jun ^a  

^a GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

Author keywords

Aciclovir; Clinical efficacy; Genital herpes; Valaciclovir

Indexed keywords

ACICLOVIR; VALACICLOVIR;

ARTICLE; COMPARATIVE STUDY; DRUG EFFECT; GENITAL HERPES; HUMAN; RECURRENT INFECTION; VIRUS SHEDDING;

EID: 79959662791     PISSN: 10004963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Koelle DM, Wald A. Herpes simplex virus: the importance of asymptomatic shedding[J]. J Antimicrob Chemother, 2000, 45 Suppl T3: 1-8. (Pubitemid 30195568)
2. Schiffer JT, Corey L. New concepts in understanding genital herpes [J]. Curr Infect Dis Rep, 2009, 11(6): 457-464.
3. Wald A, Zeh J, Bamum G, et al. Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir[J]. Ann Intern Med, 1996, 124(1 Pt 1): 8-15. (Pubitemid 26019618)
4. Corey L. Challenges in genital herpes simplex virus management[J]. J Infect Dis, 2002, 186 Suppl 1: S29-S33. (Pubitemid 35178846)
5. Reitano M, Tyring S, Lang W, et al. Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. International Valaciclovir HSV Study Group[J]. J Infect Dis, 1998, 178(3): 603-610. (Pubitemid 28397205)
6. WellerS, Blum MR, Doucette M, et al. Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers[J]. Clin Pharmacol Ther, 1993, 54(6): 595-605.
7. Handsfield HH, Warren T, Wemer M, et al. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life[J]. Sex Transm Dis, 2007, 34(6): 339-343.
8. Wald A, Selke S, Warren T, et al. Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding[J]. Sex Transm Dis, 2006, 33(9): 529-533. (Pubitemid 44318975)
9. Centers for Disease Control and Prevention (CDC). Seroprevalence of herpes simplex virus type 2 among persons aged 14-49 years-United States, 2005-2008[J]. MMWR Morb Mortal Wkly Rep, 2010, 59(15): 456-459.
10. Williams JR, Jordan JC, Davis EA, et al. Suppressive valacyclovir therapy: impact on the population spread of HSV-2 infection[J]. Sex Transm Dis, 2007, 34(3): 123-131. (Pubitemid 46673212)